SecBot SecBot
8-K ·Filed Mar 11, 2026

ACRS

Aclaris Therapeutics, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed7mo ago SEC0001104659-26-026407
8-K context-dependent: Items 7.01
Actionable Insight • Neutral

Monitor for the release of the exhibit or public presentation materials that may provide insight into strategic updates or operational progress. Absent material content, no immediate trading action is supported.

DirectionNeutral
Confidencelow
Horizondays
Final — all horizons settled through T+60d
ACRS ▲ +24.22% at T+60d
NEUTRAL call +24.22% · α vs SPY +13.52% · entry $3.51 → $4.36
Entry = T+0 close
Mar 11, 2026
via day close
T+1d
+0.85%
call +0.85% · α +1.45%
$3.54
settled 8mo ago
T+5d
+6.55%
call +6.55% · α +7.53%
$3.74
settled 7mo ago
T+20d
+15.10%
call +15.10% · α +13.12%
$4.04
settled 7mo ago
T+60d
+24.22%
call +24.22% · α +13.52%
$4.36
settled 5mo ago

Price Chart

Loading chart...

Executive Summary

Analysis based on filing metadata only — document content was unavailable. The 8-K filing includes Item 7.01 (Regulation FD Disclosure), which typically involves public dissemination of information such as investor presentations or business updates. No financial or operational details could be extracted due to missing document content.

Key Facts

  • Aclaris Therapeutics (ACRS) filed a Form 8-K with Item 7.01, indicating disclosure of information under Regulation FD.
  • Item 7.01 suggests the company may have made public statements regarding corporate developments, but no specific details are available.
  • No exhibit (e.g., EX-99.1) content was accessible to confirm the nature of the disclosure.

Financial Impact

Not specified

Risk Factors

  • Material information may have been disclosed that is not reflected in this analysis due to document unavailability.
  • Regulation FD disclosures can sometimes precede or accompany stock-moving news, creating information asymmetry risk.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Documents Analyzed

Report based on filing metadata.

11 reports for ACRS
Performance horizon
100% Hit rate @ T+5 5 of 5 directional calls Went positive at some point 5 of 5 best @ T+60▲ +47.87%Feb 28, 2026
Filters
Rows
Reports for ACRS — sortable, filterable
TypeNow
Aug 11, 2026
10w ago
Institutional Cluster
BULLISH ★ 5/10
$5.84 $6.44▲ +10.27%▲ +10.72%$3.79 (−35.10%)
Aug 6, 2026
11w ago
8-K
NEUTRAL ★ 4/10
$6.09 $5.86▼ −3.78%▼ −4.99%$3.79 (−37.77%)
Apr 28, 2026
25w ago
8-K
BULLISH ★ 8/10
$4.22 $4.75▲ +12.56%▲ +10.87%$3.79 (−10.19%)
Apr 28, 2026
25w ago
Press Release
BULLISH ★ 7/10
$4.22 $4.75▲ +12.56%▲ +10.87%$3.79 (−10.19%)
Apr 23, 2026
26w ago
DEFA14A
NEUTRAL ★ 2/10
$4.55 $4.47▼ −1.76%▼ −3.24%$3.79 (−16.70%)
Mar 27, 2026
30w ago
Press Release
BULLISH ★ 8/10
$3.52 $3.80▲ +7.95%▲ +4.09%$3.79 (+7.67%)
Mar 20, 2026
31w ago
Press Release
NEUTRAL ★ 3/10
$3.69 $3.52▼ −4.61%▼ −2.46%$3.79 (+2.71%)
Mar 18, 2026
31w ago
Press Release
NEUTRAL ★ 5/10
$3.66 $3.59▼ −1.91%▼ −1.20%$3.79 (+3.55%)
Mar 11, 2026
32w ago
8-K
NEUTRAL ★ 3/10
$3.51 $3.74▲ +6.55%▲ +7.53%$3.79 (+7.98%)
Feb 28, 2026
34w ago
Institutional Cluster
BULLISH ★ 6/10
$3.05 $3.39▲ +11.15%▲ +12.36%$3.79 (+24.27%)
Showing 10 of 11

US Market Status

Market Open — Closes in 4h 3m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 11, 2026